Literature DB >> 26519929

Synthesis and biological evaluation of negative allosteric modulators of the Kv11.1(hERG) channel.

Zhiyi Yu1, Jacobus P D van Veldhoven1, Ingrid M E 't Hart1, Adrian H Kopf1, Laura H Heitman1, Adriaan P IJzerman2.   

Abstract

We synthesized and evaluated a series of compounds for their allosteric modulation at the Kv11.1 (hERG) channel. Most compounds were negative allosteric modulators of [(3)H]dofetilide binding to the channel, in particular 7f, 7h-j and 7p. Compounds 7f and 7p were the most potent negative allosteric modulators amongst all ligands, significantly increasing the dissociation rate of dofetilide in the radioligand kinetic binding assay, while remarkably reducing the affinities of dofetilide and astemizole in a competitive displacement assay. Additionally, both 7f and 7p displayed peculiar displacement characteristics with Hill coefficients significantly distinct from unity as shown by e.g., dofetilide, further indicative of their allosteric effects on dofetilide binding. Our findings in this investigation yielded several promising negative allosteric modulators for future functional and clinical research with respect to their antiarrhythmic propensities, either alone or in combination with known Kv11.1 blockers.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiarrhythmia; K(v)11.1 blockers; K(v)11.1(hERG) channel; Negative allosteric modulator; Radioligand binding assay

Mesh:

Substances:

Year:  2015        PMID: 26519929     DOI: 10.1016/j.ejmech.2015.10.032

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Rollover Cyclometalation vs Nitrogen Coordination in Tetrapyridyl Anticancer Gold(III) Complexes: Effect on Protein Interaction and Toxicity.

Authors:  Xue-Quan Zhou; Imma Carbo-Bague; Maxime A Siegler; Jonathan Hilgendorf; Uttara Basu; Ingo Ott; Rongfang Liu; Liyan Zhang; Vadde Ramu; Adriaan P IJzerman; Sylvestre Bonnet
Journal:  JACS Au       Date:  2021-03-16

2.  A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.

Authors:  Luca Sala; Zhiyi Yu; Dorien Ward-van Oostwaard; Jacobus Pd van Veldhoven; Alessandra Moretti; Karl-Ludwig Laugwitz; Christine L Mummery; Adriaan P IJzerman; Milena Bellin
Journal:  EMBO Mol Med       Date:  2016-09-01       Impact factor: 12.137

Review 3.  Pharmacological activation of the hERG K+ channel for the management of the long QT syndrome: A review.

Authors:  Aziza El Harchi; Oriane Brincourt
Journal:  J Arrhythm       Date:  2022-06-14

Review 4.  Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.

Authors:  Karina O Brandão; Viola A Tabel; Douwe E Atsma; Christine L Mummery; Richard P Davis
Journal:  Dis Model Mech       Date:  2017-09-01       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.